Results 61 to 70 of about 75 (74)
Some of the next articles are maybe not open access.
A Stable Parenteral Solution of Apomorphine
Clinical Toxicology, 1981A sterile, stable apomorphine preparation suitable for parenteral use was prepared by dissolving 0.3% w/v powdered apomorphine hydrochloride in 1% reduced l-ascorbic acid. The solution was then sterilized by filtration through a 0.22 -micrometer Millipore filter, the air in the vial was replaced by nitrogen, and the vials were sealed and stored at 5 ...
Harold F. Combs+2 more
openaire +3 more sources
Apomorphine in the treatment of Parkinson's disease
Expert Opinion on Pharmacotherapy, 2007Motor fluctuations, refractory to conventional medical management, are one of the most troubling aspects of Parkinson's disease. Apomorphine is a dopaminergic agent that has been known to the medical community for more than a century, but has only recently been developed to treat such motor fluctuations.
Mark Stacy, Rukmini Menon
openaire +2 more sources
Scopolamine and Apomorphine in Labor
American Journal of Obstetrics and Gynecology, 1947Elwood R. Brubaker, Bert B. Hershenson
openaire +4 more sources
Journal of the American Pharmaceutical Association (1961), 1968
J. Leon Lichtin+2 more
openaire +3 more sources
J. Leon Lichtin+2 more
openaire +3 more sources
Oscillations in apomorphine-lnduced stereotypies during 1 year of apomorphine administration
Biological Psychiatry, 1986Roy J. King+3 more
openaire +3 more sources
Characteristics of Apomorphine Tachyphylaxis
1978R.C. Turowski, P.N. Patil, B.S. Turowski
openaire +2 more sources